Aspirin reduces esophageal-cancer risk in people with most-aggressive form of Barrett's esophagus
SEATTLE -- Researchers at Fred Hutchinson Cancer Research Center have found that people with the most-aggressive form of Barretts esophagus, a precancerous condition that can lead to esophageal cancer, may benefit the most from preventive therapy with aspirin, ibuprofen and other nonsteroidal anti-inflammatory drugs, or NSAIDs. The researchers also identified a cluster of four known cancer bioma...Study provides first estimate of US population affected by Barrett's esophagus
Bethesda, Maryland (Dec. 1, 2005) According to estimates put forth in a study published today in the American Gastroenterological Association (AGA) journal , more than 3 million Americans are living with Barrett's esophagus, a condition that leads to esophageal cancer, one of the most rapidly increasing cancers in the United States. These findings represent the first population-based estimates...Aspirin & similar drugs may cut risk of esophageal cancer in people with Barrett's esophagus
SEATTLE- Aspirin and other nonsteroidal anti-inflammatory drugs, such as ibuprofen, may significantly reduce the risk of esophageal cancer among people with Barrett's esophagus, a precancerous condition associated with chronic heartburn that affects an estimated 1 million to 2 million Americans....... These findings, by Thomas L. Vaughan, M.D., M.P.H., and colleagues at Fred Hutchinson Cancer Res...